Lu S - Search Results

1

Current progress of DNA vaccine studies in humans.

Lu S, Wang S, Grimes-Serrano JM. Lu S, et al. Expert Rev Vaccines. 2008 Mar;7(2):175-91. doi: 10.1586/14760584.7.2.175. Expert Rev Vaccines. 2008. PMID: 18324888 Free article. Review.

2

Simian immunodeficiency virus DNA vaccine trial in macaques.

Robinson HL, Lu S, Mustafa F, Johnson E, Santoro JC, Arthos J, Winsink J, Mullins JI, Montefiori D, Yasutomi Y, et al. Robinson HL, et al. Among authors: lu s. Ann N Y Acad Sci. 1995 Nov 27;772:209-11. doi: 10.1111/j.1749-6632.1995.tb44746.x. Ann N Y Acad Sci. 1995. PMID: 8546394 No abstract available.

3

Simian immunodeficiency virus DNA vaccine trial in macaques.

Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL. Lu S, et al. J Virol. 1996 Jun;70(6):3978-91. doi: 10.1128/JVI.70.6.3978-3991.1996. J Virol. 1996. PMID: 8648735 Free PMC article.

4

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.

Lu S, Wyatt R, Richmond JF, Mustafa F, Wang S, Weng J, Montefiori DC, Sodroski J, Robinson HL. Lu S, et al. AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):151-5. doi: 10.1089/aid.1998.14.151. AIDS Res Hum Retroviruses. 1998. PMID: 9462925

5

Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.

Yang K, Wang S, Chang KO, Lu S, Saif LJ, Greenberg HB, Brinker JP, Herrmann JE. Yang K, et al. Among authors: lu s. Vaccine. 2001 Apr 30;19(23-24):3285-91. doi: 10.1016/s0264-410x(00)00543-0. Vaccine. 2001. PMID: 11312027

6

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, Leung L, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L. Barnett SW, et al. Among authors: lu s. J Virol. 2001 Jun;75(12):5526-40. doi: 10.1128/JVI.75.12.5526-5540.2001. J Virol. 2001. PMID: 11356960 Free PMC article.

7

Delivery of DNA to skin by particle bombardment.

Wang S, Joshi S, Lu S. Wang S, et al. Among authors: lu s. Methods Mol Biol. 2004;245:185-96. doi: 10.1385/1-59259-649-5:185. Methods Mol Biol. 2004. PMID: 14707379 No abstract available.

8

Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.

Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S. Liu F, et al. Among authors: lu s. Vaccine. 2004 Apr 16;22(13-14):1764-72. doi: 10.1016/j.vaccine.2003.09.054. Vaccine. 2004. PMID: 15068860

9

[Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].

Xing YP, Huang ZH, Wang SX, Cai J, Li J, Lu S. Xing YP, et al. Among authors: lu s. Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):338-40. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15225426 Chinese.

10

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S. Wang S, et al. Among authors: lu s. Vaccine. 2004 Sep 3;22(25-26):3348-57. doi: 10.1016/j.vaccine.2004.02.036. Vaccine. 2004. PMID: 15308359 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,231 results

Search Page

Filters